Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04001283Phase 2Unknown
Phase 2, randomised, double-blind trial of sodium nitrite in coronary artery disease (CAD) (3 arms), sponsored by University of East Anglia. Primary endpoint: Metabolic protein expression in cardiac biopsies and vascular offcuts. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04001283.